Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments

P Goodarzi, F Mahdavi, R Mirzaei, H Hasanvand… - International …, 2020 - Elsevier
The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …

The development of COVID-19 treatment

Y Yuan, B Jiao, L Qu, D Yang, R Liu - Frontiers in immunology, 2023 - frontiersin.org
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused
a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest …

Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview

LM Khosroshahi, M Rokni, T Mokhtari… - International …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …

A 21st century evil: immunopathology and new therapies of COVID-19

TF Silva, F Tomiotto-Pellissier, RA Sanfelice… - Frontiers in …, 2020 - frontiersin.org
Coronavirus Disease 2019 (COVID-19) has been classified as a global threat, affecting
millions of people and killing thousands. It is caused by the SARS-CoV-2 virus, which …

[HTML][HTML] Recent insight into SARS-CoV2 immunopathology and rationale for potential treatment and preventive strategies in COVID-19

S Lega, S Naviglio, S Volpi, A Tommasini - Vaccines, 2020 - mdpi.com
As the outbreak of the new coronavirus (SARS-CoV-2) infection is spreading globally, great
effort is being made to understand the disease pathogenesis and host factors that …

Advances in immunotherapy for COVID-19: A comprehensive review

M Masoomikarimi, B Garmabi, J Alizadeh… - International …, 2021 - Elsevier
COVID-19 is an acute respiratory syndrome caused by SARS-COV-2 which has now
become a huge pandemic worldwide. The immunopathogenesis of COVID-19 has been …

COVID-19 infection: concise review based on the immunological perspective

P Lotfinejad, Z Asadzadeh, S Najjary… - Immunological …, 2022 - Taylor & Francis
The outbreak of coronavirus disease 2019 (COVID-19) has posed a serious threat to public
health. There is an urgent need for discovery methods for the prevention and treatment of …

Pathogenesis guided therapeutic management of COVID-19: an immunological perspective

A Kumar, P Prasoon, PS Sekhawat… - International Reviews …, 2021 - Taylor & Francis
Lack of standardized therapeutic approaches is arguably the significant contributor to the
high burden of mortality observed in the ongoing pandemic of the Coronavirus disease …

Immunobiology and immunotherapy of COVID‐19: A clinically updated overview

A Esmaeilzadeh, R Elahi - Journal of cellular physiology, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new member of the
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …

COVID-19 and the immune response: A multi-phasic approach to the treatment of COVID-19

T Sapir, Z Averch, B Lerman, A Bodzin… - International Journal of …, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a viral agent that causes
Coronavirus disease 2019 (COVID-19), a disease that causes flu-like symptoms that, when …